The oral cavity represents a unique body part that is in contact with the external world and therefore constantly encounters a vast diverse of microbes. Herpesviruses are significant resident oral pathogens in humans. However, little is known about how the host senses and responds to herpesviruses during primary infection, latency and reactivation in the oral cavity, especially in regards to the innate immune system. Coexistence of a virus and its immunocompetent host entails a delicate balance between viral replication and host clearance. Elucidating the interactions between the innate immune system and herpesviruses will provide insights to how the balance is accomplished and regulated. A mouse model of murine gammaherpesvirus-68 (MHV-68) infection provides an excellent system to explore virus-host interactions in the oral cavity for several reasons. First, following oral administration, MHV-68 replicates in the oronasal cavity and the salivary gland. Second, an amenable genetic system is available to mutagenize the MHV-68 viral genome. Third, MHV-68 infects a variety of laboratory strains of mice, which allows the role of cellular genes during viral infection to be studied in vivo. ? ? The long-term goal of our discovery driven approach is to determine the role of viral and cellular proteins in virus-associated pathogenesis by employing knock-out mice and a collection of MHV-68 mutant viruses. The MHV-68 genome is randomly disrupted by an insertion of a transponson. There are 32 viral ORFs that are not required for replication in fibroblast cells and potentially involved in modulating virus-host interactions. The object of this exploratory R21 application is to define the in vivo sensing and defending role of TLR and its signaling pathway using a mouse model of oral MHV-68 infection. Furthermore, we will systematically screen viral genes that are capable of inhibiting the activation of anti-viral responses in cells, an essential step for understanding virus-host interactions. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DE018337-01
Application #
7277107
Study Section
Special Emphasis Panel (ZDE1-YL (20))
Program Officer
Rodriguez-Chavez, Isaac R
Project Start
2007-08-22
Project End
2009-07-31
Budget Start
2007-08-22
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$231,000
Indirect Cost
Name
University of California Los Angeles
Department
Dentistry
Type
Schools of Dentistry
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Leang, Ronika Sitapara; Wu, Ting-Ting; Hwang, Seungmin et al. (2011) The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection. PLoS Pathog 7:e1002292
Wu, Ting-Ting; Liao, Hsiang-I; Tong, Leming et al. (2011) Construction and characterization of an infectious murine gammaherpesivrus-68 bacterial artificial chromosome. J Biomed Biotechnol 2011:926258
Jia, Qingmei; Freeman, Michael L; Yager, Eric J et al. (2010) Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency. J Virol 84:2453-65
Freeman, Michael L; Lanzer, Kathleen G; Cookenham, Tres et al. (2010) Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J Virol 84:2881-92
Wu, Ting-Ting; Blackman, Marcia A; Sun, Ren (2010) Prospects of a novel vaccination strategy for human gamma-herpesviruses. Immunol Res 48:122-46
Arumugaswami, Vaithilingaraja; Sitapara, Ronika; Hwang, Seungmin et al. (2009) High-resolution functional profiling of a gammaherpesvirus RTA locus in the context of the viral genome. J Virol 83:1811-22
Wu, Ting-Ting; Park, Tina; Kim, Hana et al. (2009) ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol 83:2265-73
Hwang, Seungmin; Wu, Ting-Ting; Tong, Leming M et al. (2008) Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J Virol 82:12498-509